HomeKRON • NASDAQ
add
Kronos Bio Inc
Previous close
$1.03
Day range
$1.00 - $1.04
Year range
$0.69 - $1.59
Market cap
61.24M USD
Avg Volume
298.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 2.37M | 158.45% |
Operating expense | 18.09M | -47.94% |
Net income | -14.11M | 55.03% |
Net profit margin | -595.27 | 82.60% |
Earnings per share | — | — |
EBITDA | -15.30M | 54.06% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 124.86M | -33.13% |
Total assets | 150.02M | -36.96% |
Total liabilities | 38.90M | -34.49% |
Total equity | 111.13M | — |
Shares outstanding | 60.34M | — |
Price to book | 0.56 | — |
Return on assets | -25.00% | — |
Return on capital | -27.36% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -14.11M | 55.03% |
Cash from operations | -12.37M | 45.23% |
Cash from investing | 17.13M | -52.14% |
Cash from financing | -1.00K | — |
Net change in cash | 4.76M | -63.97% |
Free cash flow | -6.79M | 40.11% |
About
Founded
2017
Headquarters
Website
Employees
58
